Hemogenyx Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,666,667 | 0.124% |
Public Companies | 3,094,528 | 0.231% |
Individual Insiders | 122,231,632 | 9.11% |
Institutions | 514,844,095 | 38.4% |
General Public | 699,979,066 | 52.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
133,325,153 | US$2.3m | 4.56% | 0.02% | |||
109,354,783 | US$1.9m | 10.5% | 0.15% | |||
90,894,346 | US$1.6m | 4.11% | 0.02% | |||
75,090,685 | US$1.3m | 0% | no data | |||
50,632,243 | US$866.8k | -1.37% | no data | |||
41,544,677 | US$711.2k | 0% | no data | |||
18,022,381 | US$308.5k | 10.5% | 0.02% | |||
13,000,000 | US$222.6k | 33.3% | 0.01% | |||
11,873,018 | US$203.3k | -69.1% | 0.08% | |||
11,371,429 | US$194.7k | 0% | no data | |||
11,066,667 | US$189.5k | 0% | 100.0% | |||
9,558,287 | US$163.6k | 9.75% | no data | |||
8,500,161 | US$145.5k | 36.4% | 0.06% | |||
7,731,614 | US$132.4k | -1.4% | no data | |||
5,596,270 | US$95.8k | 0% | no data | |||
5,458,322 | US$93.4k | 61.5% | no data | |||
4,936,500 | US$84.5k | 0% | no data | |||
4,689,665 | US$80.3k | -28.6% | no data | |||
3,853,051 | US$66.0k | 0% | no data | |||
3,773,200 | US$64.6k | 0% | no data | |||
3,094,528 | US$53.0k | -1.65% | no data | |||
3,084,253 | US$52.8k | 2.55% | no data | |||
3,039,212 | US$52.0k | 0.34% | no data | |||
2,595,499 | US$44.4k | 0% | 0.15% | |||
1,666,667 | US$28.5k | 0% | no data |